[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

YU40087B - Process for obtaining new heterocyclic compounds - Google Patents

Process for obtaining new heterocyclic compounds

Info

Publication number
YU40087B
YU40087B YU1921/82A YU192182A YU40087B YU 40087 B YU40087 B YU 40087B YU 1921/82 A YU1921/82 A YU 1921/82A YU 192182 A YU192182 A YU 192182A YU 40087 B YU40087 B YU 40087B
Authority
YU
Yugoslavia
Prior art keywords
heterocyclic compounds
obtaining new
new heterocyclic
obtaining
compounds
Prior art date
Application number
YU1921/82A
Other languages
English (en)
Other versions
YU192182A (en
Inventor
C Cortel
C Crisan
C Jeanmart
M N Messer
Original Assignee
Rhone Poulenc Sante
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7436963A external-priority patent/FR2313060A1/fr
Priority claimed from FR7527161A external-priority patent/FR2322601A1/fr
Priority claimed from FR7527162A external-priority patent/FR2322602A1/fr
Priority claimed from FR7527160A external-priority patent/FR2322600A1/fr
Application filed by Rhone Poulenc Sante filed Critical Rhone Poulenc Sante
Publication of YU192182A publication Critical patent/YU192182A/xx
Publication of YU40087B publication Critical patent/YU40087B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
YU1921/82A 1974-11-07 1982-08-26 Process for obtaining new heterocyclic compounds YU40087B (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR7436963A FR2313060A1 (fr) 1974-11-07 1974-11-07 Nouveaux derives de l'isoindoline, leur preparation et les compositions qui les contiennent
FR7527161A FR2322601A1 (fr) 1975-09-04 1975-09-04 Nouveaux derives de l'isoindoline, leur preparation et les compositions qui les contiennent
FR7527162A FR2322602A1 (fr) 1975-09-04 1975-09-04 Nouveaux derives de l'oxathiinno- et du dithiinnopyrrole, leur preparation et les compositions qui les contiennent
FR7527160A FR2322600A1 (fr) 1975-09-04 1975-09-04 Nouveaux derives de la pyrrolo (3,4-b) pyrazine, leur preparation et les compositions qui les contiennent

Publications (2)

Publication Number Publication Date
YU192182A YU192182A (en) 1983-01-21
YU40087B true YU40087B (en) 1985-06-30

Family

ID=27446274

Family Applications (2)

Application Number Title Priority Date Filing Date
YU2815/75A YU39583B (en) 1974-11-07 1975-11-07 Process for obtaining new heterocyclic compounds
YU1921/82A YU40087B (en) 1974-11-07 1982-08-26 Process for obtaining new heterocyclic compounds

Family Applications Before (1)

Application Number Title Priority Date Filing Date
YU2815/75A YU39583B (en) 1974-11-07 1975-11-07 Process for obtaining new heterocyclic compounds

Country Status (27)

Country Link
US (1) US4220646A (xx)
JP (2) JPS5422996B2 (xx)
AR (2) AR208414A1 (xx)
AT (2) AT343123B (xx)
AU (1) AU503200B2 (xx)
BE (1) BE835325A (xx)
CA (1) CA1057755A (xx)
CH (1) CH609057A5 (xx)
CS (2) CS231957B2 (xx)
CY (1) CY1045A (xx)
DD (1) DD122684A5 (xx)
DE (1) DE2550111C2 (xx)
DK (1) DK141098B (xx)
FI (1) FI60707C (xx)
GB (1) GB1468497A (xx)
HK (1) HK19380A (xx)
HU (1) HU173108B (xx)
IE (1) IE41928B1 (xx)
IL (1) IL48423A (xx)
LU (1) LU73738A1 (xx)
NL (1) NL177405C (xx)
NO (1) NO143576C (xx)
OA (1) OA05162A (xx)
PL (1) PL101248B1 (xx)
SE (1) SE407063B (xx)
SU (2) SU673173A3 (xx)
YU (2) YU39583B (xx)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2371198A2 (fr) * 1976-11-22 1978-06-16 Rhone Poulenc Ind Nouveaux derives du dithiepinno (1,4)(2,3-c) pyrrole, leur preparation et les compositions qui les contiennent
US4533751A (en) * 1981-10-09 1985-08-06 Scm Corporation Preparation of 1,3-dienamines from myrcene and substituted myrcene
FR2525606A1 (fr) * 1982-04-22 1983-10-28 Rhone Poulenc Sante Nouveaux derives du dithiino (1,4) (2,3-c) pyrrole, leur preparation et les medicaments qui les contiennent
FR2607506B1 (fr) * 1986-12-02 1989-01-06 Rhone Poulenc Sante Nouveaux derives de l'isoindolinone, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2607504B1 (fr) * 1986-12-02 1989-01-27 Rhone Poulenc Sante Nouveaux derives de l'isoindolinone, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2671800B1 (fr) * 1991-01-17 1993-03-12 Rhone Poulenc Rorer Sa Derive de la 5h-pyrrolo[3,4-b]pyrazine optiquement actif, sa preparation et les compositions pharmaceutiques qui le contiennent.
US5786357A (en) * 1991-12-02 1998-07-28 Sepracor Inc. Methods and compositions for treating sleep disorders, convulsive seizures and other disorders using optically pure (+) zopiclone
HU214331B (hu) * 1992-06-17 1998-03-02 Gyógyszerkutató Intézet Kft. Eljárás piperazin- és homopiperazinszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására
US5922820A (en) * 1993-06-04 1999-07-13 Henkel Corporation Polymerizable compounds
US5565567A (en) * 1993-06-04 1996-10-15 Henkel Corporation. Polymerizable N,N'-substituted piperazine acrylamide compounds
CN1126474A (zh) * 1993-06-04 1996-07-10 亨凯尔公司 聚合的化合物
KR970706267A (ko) * 1994-09-23 1997-11-03 다니엘 에이치. 페트리 비만 세포 염증성 질환 치료용 조성물 및 방법(compositions and methods for treating mast-cell inflammatory condition)
US5663357A (en) 1995-11-22 1997-09-02 Allergan Substituted heteroarylamides having retinoid-like biological activity
US5756742A (en) * 1995-12-22 1998-05-26 Henkel Corporation Polymerizable compounds
US6339086B1 (en) 1999-05-14 2002-01-15 Swpracor, Inc. Methods of making and using N-desmethylzopiclone
EP1396493A4 (en) * 2001-04-26 2005-08-03 Ajinomoto Kk HETEROCYCLIC COMPOUNDS
CA2480776C (en) * 2002-03-29 2010-11-23 Indevus Pharmaceuticals, Inc. Methods of preparation of the 2-(7-chloro-1,8-naphthyridine-2yl)-3-(5-methyl-2-oxo-hexyl)-1-isoindolinone
WO2004037212A2 (en) * 2002-10-24 2004-05-06 Sepracor, Inc. Compositions comprising zopiclone derivatives and methods of making and using the same
US6909002B2 (en) * 2002-11-22 2005-06-21 Merck & Co., Inc. Method of preparing inhibitors of phosphodiesterase-4
UA79518C2 (en) * 2002-11-22 2007-06-25 Merck & Co Inc Process for preparation of phosphodiesterase-4 inhibitors
AR042194A1 (es) * 2002-11-22 2005-06-15 Merck & Co Inc Metodo para preparar inhibidores de fosfodiesterasa - 4
CA2548917C (en) 2003-12-11 2014-09-23 Sepracor Inc. Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression
US20050232983A1 (en) * 2004-04-14 2005-10-20 Indevus Pharmaceuticals, Inc. Transdermal patch
AU2006264317B2 (en) 2005-07-06 2012-02-23 Sunovion Pharmaceuticals Inc. Combinations of eszopiclone and trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-napthalenamine or trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine, and methods of treatment of menopause and mood, anxiety, and cognitive disorders
CA2614209A1 (en) * 2005-07-06 2007-01-11 Sepracor Inc. Combinations of eszopiclone and o-desmethylvenlafaxine, and methods of treatment of menopause and mood, anxiety, and cognitive disorders
EP2258358A3 (en) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
US7678363B2 (en) 2005-08-26 2010-03-16 Braincells Inc Methods of treating psychiatric conditions comprising administration of muscarinic agents in combination with SSRIs
EP1940389A2 (en) 2005-10-21 2008-07-09 Braincells, Inc. Modulation of neurogenesis by pde inhibition
EP2314289A1 (en) 2005-10-31 2011-04-27 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
WO2007134136A2 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
JP2009536667A (ja) 2006-05-09 2009-10-15 ブレインセルス，インコーポレイティド ５ｈｔ受容体介在性の神経新生
WO2008030651A1 (en) 2006-09-08 2008-03-13 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
US20080305171A1 (en) * 2007-06-07 2008-12-11 Kristin Anne Arnold Pyrrolopyrazine, formulations, methods of manufacture, and methods of use there
CN100569775C (zh) * 2007-12-19 2009-12-16 齐鲁天和惠世制药有限公司 佐匹克隆的晶型转换的方法
JP2012516348A (ja) 2009-01-30 2012-07-19 サノビオン ファーマシューティカルズ インク ６−（５−クロロ−２−ピリジル）−５−［（４−メチル−１−ピペラジニル）カルボニルオキシ］−７−オキソ−６，７−ジヒドロ−５Ｈ−ピロロ［３，４−ｂ］ピラジンの被覆錠剤及びコーティングの効果を測定する方法
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
JP6984656B2 (ja) * 2017-05-25 2021-12-22 信越化学工業株式会社 フルオロポリエーテル基含有ポリマー変性有機ケイ素化合物、表面処理剤及び物品
CN108129476A (zh) * 2017-11-27 2018-06-08 华中农业大学 一种杂环内酰胺衍生物及其用于作物病原菌杀菌剂的用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1312427A (fr) * 1961-04-12 1962-12-21 Science Union Et Compagnie Soc Nouveaux dérivés de la pipérazine et leurs préparations
FR2101081B1 (xx) * 1970-08-19 1974-01-11 Rhone Poulenc Sa
BE790408A (fr) * 1971-10-22 1973-04-20 Rhone Poulenc Sa Nouveaux derives de la pyrrolo (3,4-b) pyridine, leur preparation et les compositions medicinales qui les
OA04285A (fr) * 1972-01-07 1979-12-31 Rhone Poulenc Sa Nouveaux dérivés de la pyrrolo (3,4-b) pyrazine et leur préparation.
BE793851A (fr) * 1972-01-10 1973-07-10 Rhone Poulenc Sa Nouveaux derives de l'isoindoline, leur preparation et les compositions medicinales qui les contiennent
AR207555A1 (es) * 1972-12-04 1976-10-15 Procedimiento para preparar aril-6-piperazinocarboniloxi-5 oxo-7 tetrahidro-2,3,6,7 ditiino(1,4)(2,3-c)pirroles
OA04700A (fr) * 1973-05-15 1980-07-31 Rhone Poulenc Sa Nouveaux dérivés de la naphtyridine et leur procédé de préparation.

Also Published As

Publication number Publication date
AU503200B2 (en) 1979-08-30
NL177405B (nl) 1985-04-16
CA1057755A (fr) 1979-07-03
AT343123B (de) 1978-05-10
US4220646A (en) 1980-09-02
IL48423A (en) 1979-03-12
SU673173A3 (ru) 1979-07-05
SE7512477L (sv) 1976-05-10
SE407063B (sv) 1979-03-12
YU281575A (en) 1983-01-21
FI60707B (fi) 1981-11-30
JPS5170776A (xx) 1976-06-18
IE41928L (en) 1976-05-07
DE2550111A1 (de) 1976-05-13
CS231957B2 (en) 1985-01-16
YU192182A (en) 1983-01-21
ATA848675A (de) 1977-09-15
JPS5422996B2 (xx) 1979-08-10
FI753127A (xx) 1976-05-08
AU8633175A (en) 1977-05-12
CY1045A (en) 1980-08-01
AT343666B (de) 1978-06-12
FI60707C (fi) 1982-03-10
HU173108B (hu) 1979-02-28
CH609057A5 (xx) 1979-02-15
NL177405C (nl) 1985-09-16
NL7512732A (nl) 1976-05-11
ATA401977A (de) 1977-10-15
AR208414A1 (es) 1976-12-27
DK141098B (da) 1980-01-14
OA05162A (fr) 1981-01-31
NO753713L (xx) 1976-05-10
DD122684A5 (xx) 1976-10-20
GB1468497A (en) 1977-03-30
IL48423A0 (en) 1976-01-30
CS751075A2 (en) 1984-01-16
NO143576B (no) 1980-12-01
NO143576C (no) 1981-03-11
IE41928B1 (en) 1980-04-23
DK141098C (xx) 1980-07-07
DK499275A (xx) 1976-05-08
HK19380A (en) 1980-04-18
BE835325A (fr) 1976-05-06
CS231958B2 (en) 1985-01-16
CS598377A2 (en) 1984-01-16
YU39583B (en) 1985-03-20
LU73738A1 (xx) 1976-09-06
JPS558508B2 (xx) 1980-03-04
DE2550111C2 (de) 1983-09-15
PL101248B1 (pl) 1978-12-30
AR208800A1 (es) 1977-02-28
JPS5498790A (en) 1979-08-03
SU604496A3 (ru) 1978-04-25

Similar Documents

Publication Publication Date Title
YU39583B (en) Process for obtaining new heterocyclic compounds
YU37308B (en) Process for obtaining 3-aryloxy-3-phenyl-propylamine compounds
YU176475A (en) Process for preparing new yrazolium compounds
YU40258B (en) Process for obtaining new 4-(3-subt.-4-methoxy-phenyl)-2-pyrrolidones
YU203476A (en) Process for obtaining new sulfonyl-benzimidazole compounds
YU56075A (en) Process for obtaining new 2-arylamino-2-imidazoline derivatives
YU39744B (en) Process for obtaining new rifamycins
YU197075A (en) Process for obtaining cephalosporinic compounds
YU323775A (en) Process for obtaining new cephalosporin compounds
YU40631B (en) Process for obtaining substituted thiolacarbamates
YU76681A (en) Process for obtaining new thiaprostaglandin derivatives
YU113176A (en) Process for preparing new thiazoline compounds
YU293975A (en) Process for obtaining phenylpyridylamine derivatives
YU86976A (en) Process for obtaining new heterocyclic compounds
YU40449B (en) Process for obtaining new dianhydrodulcite derivatives
HU171670B (hu) Sposob poluchenija nitril'nykh soedinenij oktenov
HU175226B (hu) Sposob poluchenija soedinenij tipa sul'finil-azetidinona
YU36721B (en) Process for obtaining cycloalkane-zbcthienylurea compounds
YU37350B (en) Process for obtaining new benzhydryloxy-alkylamine derivatives
YU39945B (en) Process for obtaining new thieno-pyridine derivatives
YU41275A (en) Process for preparing new cephemic compounds
YU35891B (en) Process for obtaining 3-cephem-3-sulfonate derivatives
HU173555B (hu) Sposob poluchenija 11beta-gidroksi-18-metil-ehstrannykh soedinenij
YU351974A (en) Process for preparing new organic compounds
YU52675A (en) Process for obraining dibenzocycloheptapyrrol derivatives